EN1 and triple-negative breast carcinoma: The evaluation of EN1 protein by immunohistochemistry has been perplexing, with Kim and colleagues previously describing EN1 protein expression as being associated with improved survival in triple-negative breast cancer, opposite to that of EN1 RNA [51].